Abraxane trial in adv #lungcancer is “positive” for improved resp rate, but survival data important & not yet reported. http://bit.ly/aGfEWf

Related posts:

Abraxane results a positive tr… Abraxane results a positive trial in #lungcancer, but is it vanilla with sprinkle...

Carbo/Abraxane v. carbo/taxol … Carbo/Abraxane v. carbo/taxol in adv #NSCLC: signif higher RR w/Abraxane: 33% v...

Large trial of COX-2 inhibitor… Large trial of COX-2 inhibitor celebrex (celecoxib) + chemo in adv NSCLC shows modes...

Want your challenging #lungcan… Want your challenging #lungcancer case discussed by several experts &made int...

RT @lccure: new NSCLC #lungcan… RT @lccure: new NSCLC #lungcancer staging system announced by Detterbeck et al o...